InsidersTradesSigma
Track the TLX stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Healthcare & Pharma sector, TLX has logged 10 insider filings. Market capitalisation: €5.1bn. The latest transaction was disclosed on 23 July 2026 (Change in Substantial Holding). Among the most active insiders: There was a change in the interests of the. Every trade is free.
10
Insider Decl.
n/a
Thresholds
€607,977
2 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate TLX Strong Buy (bullish), based on 13 analysts. Average price target: A$23.48.
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,613 of 28,855 companies
34.6
score / 100
Value32
Quality38
FCF yld-1.5%
Earn yld-0.2%
EV/EBITDA·
ROE7.4%
Gross mgn53%
Net mgn-0.9%
Debt/EBITDA13.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 July 2026
Declarations10 total
ShareASXASX:2924-03113759-3A697553
ShareASXASX:2924-03097995-3A694873
ShareASXASX:2924-03089990-3A693283
ShareASXASX:2924-03089979-3A693279
ShareASXASX:2924-03089977-3A693278
67,935 shares@ A$14.67140.016% mcap100.0% of flowShareASXASX:2924-03084212-3A692242
ShareASXASX:2924-03083454-3A692125
10 of 10 declarations
About TLX
TLX is a company in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.
